Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3011158388.
Observations9
Issue DateNovember 15, 2019
StatusNo Warning Letter
Establishment TypeOutsourcing Facility
Related Inspections0
Establishment Details
Firm
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Location
South Carolina, United States
FEI Number
3011158388
Establishment Type
Outsourcing Facility
Product Type
Outsourcing Facility
Issue Date
November 15, 2019
Country
United States
Inspection History
We hold no FDA inspection matched to this establishment.